Summary:Bone marrow contains a population of rare progenitor cells capable of differentiating into bone, cartilage. tendon, and other connective tissues. These cells. referred to as mesenchymal stem cells, can be purified and culture-expanded from animals and humans and have been shown to regencrate functional tissue when delivered to the site of musculoskeletal defects in experimental animal$. To test the ability of purified human mesenchymal stem cells to heal a clinically significant bone defect, mesenchymal stem cells isolated from normal human bone marrow were culture-expanded, loaded onto a ceramic carrier, and implanted into critical-sized segmental defects in the femurs of adult athymic rats. For comparison, cell-free ceramics were implanted in the contralateral limb. The animals were euthanized at 4,8, or 12 weeks, and healing bone defects were compared by high-resolution radiography, immunoliistochemistry. quantitative histomorphometry. and biomechanical testing. In mesenchymal stem cell-loaded samples, radiographic and histologic evidence of new bone was apparent by 8 weeks and histoniorphometry demonstrated increasing bone formation through 12 weeks. Biomechanical evaluation confirmed that femurs implanted with mesenchymal stem cell-loaded ceramics were significantly stronger than those that received cell-lree ceramics. These studies demonstrate that human mesenchymal stern cells can regenerate bone in a clinically significant osscous defect and may therefore provide an alternative to autogcnous bone grafts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.